Oh, so first it was your insto analyst mate, now it’s you making the call yourself and passing it off as your insto mate’s analysis? You’re making very broad assumptions from saying FDA disallowing a head to head from the COBRA trial.
My information is directly from the CU6 announcements: the initial readout COBRA trial and the Half yearly reports. Yours was from a “Insto analyst” that has suddenly become your interpretation. The rest of your insto analyst mate’s message to you stated other information that isn’t public either. Is this also just your interpretation to pass off again?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.38 |
Change
0.290(13.9%) |
Mkt cap ! $749.0M | |||
| Open | High | Low | Value | Volume |
| $2.09 | $2.38 | $2.07 | $7.536M | 3.349M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 16865 | $2.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.38 | 23547 | 10 |
View Market Depth
| Last trade - 15.28pm 26/06/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |